Breaking Finance News

HSBC Securities downgraded Sociedad Quimica y Minera S.A. (NYSE:SQM) from Buy to Reduce in a report released today.

Just yesterday Sociedad Quimica y Minera S.A. (NYSE:SQM) traded -2.28% lower at $56.89. Sociedad Quimica y Minera S.A.’s 50-day moving average is $53.08 and its 200-day moving average is $40.72. The last closing price is up 41.20% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has increased 0.03% over the same time period. 511,294 shares of SQM traded hands, down from an average trading volume of 1,175,220

HSBC Securities has downgraded Sociedad Quimica y Minera S.A. (NYSE:SQM) from Buy to Reduce in a report released on 10/11/2017.

Recent Performance Chart

Sociedad Quimica y Minera S.A. (NYSE:SQM)

Sociedad Quimica y Minera S.A. has price-earnings ratio of 54.25 with a one year low of $26.28 and a one year high of $63.80 and has a total market value of $0.

Brief Synopsis About Sociedad Quimica y Minera S.A. (NYSE:SQM)

Sociedad Quimica y Minera de Chile S.A. (SQM), is a producer of potassium nitrate and iodine. The Company produces specialty plant nutrients, iodine derivatives, lithium and its derivatives, potassium chloride, potassium sulfate and certain industrial chemicals. Its segments include specialty plant nutrients, industrial chemicals, iodine and derivatives, lithium and derivatives, potassium, and other products and services. Specialty plant nutrients are fertilizers that enable farmers to improve yields and the quality of certain crops. Industrial chemicals have a range of applications in chemical processes, such as the manufacturing of glass and industrial nitrates. Iodine and its derivatives are used in the X-ray contrast media and biocides industries, among others. Lithium and its derivatives are used in batteries, greases and frits for production of ceramics. Potassium chloride is a commodity fertilizer that is produced and sold by the Company across the world.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.